# Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function

> **NCT00943059** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 31 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Cardiomyopathy, Dilated

## Interventions

- **DRUG:** Acipimox
- **DRUG:** Cellulosum Mycrocryst

## Key facts

- **NCT ID:** NCT00943059
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943059, "Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00943059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*